Indegene and Microsoft Collaborate to Scale Up Generative AI Adoption in Life Sciences

Indegene, a leading provider of technology-driven solutions for life sciences companies, has announced a strategic collaboration with Microsoft to help life sciences companies scale up the adoption of enterprise-grade Generative AI (GenAI) services. The collaboration aims to develop resources and co-innovate GenAI services and workflows across commercial, medical, regulatory, and clinical functions. According to Indegene's CTO, Tarun Mathur, this collaboration offers a significant opportunity for life sciences companies to modernize their business processes and reimagine the effectiveness and efficiency of their operations. Microsoft India & South Asia's Chief Operating Officer, Alok Lall, emphasized the transformative potential of GenAI in the life sciences sector and Microsoft's commitment to advancing this technology within the industry.